One bad thing. A buyout of GNTA seems impossible. I can't imagine any Big Pharma company wanting to buy GNTA with mega noteholders on the balance sheet. That means if GNTA is going to hit pay dirt, it will have to do it on its own engine--which of course is possible.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.